Does ACLARUBICIN Cause Myelosuppression? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Myelosuppression have been filed in association with ACLARUBICIN. This represents 25.5% of all adverse event reports for ACLARUBICIN.
80
Reports of Myelosuppression with ACLARUBICIN
25.5%
of all ACLARUBICIN reports
3
Deaths
20
Hospitalizations
How Dangerous Is Myelosuppression From ACLARUBICIN?
Of the 80 reports, 3 (3.8%) resulted in death, 20 (25.0%) required hospitalization, and 6 (7.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACLARUBICIN. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does ACLARUBICIN Cause?
Bone marrow failure (73)
Off label use (38)
Nausea (35)
Infection (26)
Acute myeloid leukaemia (24)
Product use in unapproved indication (22)
Platelet count decreased (21)
Febrile neutropenia (19)
Pneumonia (19)
Thrombocytopenia (18)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which ACLARUBICIN Alternatives Have Lower Myelosuppression Risk?
ACLARUBICIN vs ACLIDINIUM
ACLARUBICIN vs ACLIDINIUM\FORMOTEROL
ACLARUBICIN vs ACORAMIDIS
ACLARUBICIN vs ACTEMRA
ACLARUBICIN vs ACTIQ